Newsvine
  • Welcome
  • Help
  • Report Bug
  • Conversation Tracker
  • Your Column
  • Replies
  • Friends
Type Comments Since You Last CheckedArticle Source Last Checked Stop Tracking All Clear Tracking All
Advertise | AdChoices
Log In | Register
Close the Login Panel
Existing users log in below. New users please register for a free account.

New Users:

Existing Users:

E-Mail:
Password:
Forgot Password?
Please enter the e-mail address or domain name you registered with:
E-Mail/Domain:
Back to Login
Log Out
  • Top News
  • Local News
  • World
  • U.S.
  • Sports
  • Politics
  • Tech
  • Entertainment
  • Science
  • Business
  • Health
  • Odd News
  • More
    • Arts
    • Education
    • Environment
    • Fashion
    • History
    • Home & Garden
    • Not News
    • Religion
    • Travel
Visit JCAtom's column >>

JCATOM

Absquatulating with the folderol.
Articles Posted: 10  Links Seeded: 1427
Member Since: 4/2008  Last Seen: 5/16/2012

What is Newsvine?

Updated continuously by citizens like you, Newsvine is an instant reflection of what the world is talking about at any given moment.

Get a Free Account
Help
Fun Stuff
  • Your Clippings
  • Leaderboard
  • E-Mail Alerts
  • Top of the Vine
  • Newsvine Live
  • Newsvine Archives
  • The Greenhouse
  • Recommended Articles
  • Wall of Vineness
Put a Seed Newsvine link on your own site

Advances on Hard to Treat Lung Cancer and Melanoma

Seeded on Mon Jun 7, 2010 9:47 AM EDT
Read ArticleArticle Source: The New York Times
health, cancer, japan, medicine, medical, drug, south-korea, disease, fda, human, cure, doctor, boston, public, therapy, protein, radiation, pharma, prostate-cancer, genes, lung-cancer, gene, chemotherapy, immune-system, met, tumor, genome, genetic, suffering, bronx, berkeley, food-and-drug-administration, university-of-california, american-cancer-society, santa-monica, melanoma, roche, cancer-cure, new-england-journal-of-medicine, bristol-myers-squibb, crizotinib, cancer-vaccine, drug-company, cure-for-cancer, human-suffering, nontoxic, memorial-sloan-kettering-cancer-center, dana-farber-cancer-institute, provenge, alk, t-cell, phizer, b-raf, ipilimumab, drug-agency, american-society-of-clinical-oncology, genetic-abnormality, genetic-treatment, angeles-clinic-and-research-institute, ctla-4, eml4, fusion-protein, jichi-medical-university, montefiore-einstein-center-for-cancer-care, plexxikon
Seeded by JCAtom
Advertise | AdChoices


Using two opposite strategies, one focused and one broad, scientists say they have made progress in taming two of the most intractable types of cancer.

More Articles

  • Enjoy this article? Help vote it up the 'Vine.

Published to:

  • JCAtom's Column, All of Newsvine
  • Groups: Daily Did You Know?, HealthVine, Newsvine Optimist Club, Newsvine Science, Open Mic, Successful Solutions, Sweeter Fennel
  • Regions: Chicago, New York
  • Public Discussion (5)
JCAtom

The focused approach shrank tumors significantly in a majority of patients with advanced lung cancer marked by a specific genetic abnormality.

The broader strategy uses a drug that could potentially become a universal treatment for all types of cancer. It works by releasing a brake on the body’s immune system, letting the immune system attack the cancer more vigorously.

  • 4 votes
Reply#1 - Mon Jun 7, 2010 9:49 AM EDT
Elaine-1503791

Great news for all cancer patients, and thank goodness for modern cancer research. We're seeing some real breakthroughs.

  • 3 votes
Reply#2 - Mon Jun 7, 2010 10:50 AM EDT
JCAtom

It seems like this kind of news is coming more and more often.

  • 2 votes
#2.1 - Mon Jun 7, 2010 10:56 AM EDT
Reply
jbdaad

Thx JC,

Efforts to harness the immune system to fight cancer have suffered setback after setback. Because tumor cells are mutated forms of the body’s own cells, not an invading pathogen, they do not usually elicit a strong immune response.

How to get the cells to register.

  • 2 votes
Reply#3 - Mon Jun 7, 2010 10:57 AM EDT
Dowser

Great news! Thanks so much for the seed!

  • 2 votes
Reply#4 - Wed Jun 9, 2010 12:15 AM EDT
Leave a Comment:
You're in Easy Mode. If you prefer, you can use XHTML Mode instead.
You're in XHTML Mode. If you prefer, you can use Easy Mode instead.
(XHTML tags allowed - a,b,blockquote,br,code,dd,dl,dt,del,em,h2,h3,h4,i,ins,li,ol,p,pre,q,strong,ul)
Newsvine Privacy Statement
As a new user, you may notice a few temporary content restrictions. Click here for more info.
FUN STUFF:
  • Leaderboard |
  • E-Mail Alerts |
  • Top of the Vine |
  • Newsvine Live |
  • Newsvine Archives |
  • The Greenhouse |
COMPANY STUFF:
  • Code of Honor |
  • Company Info |
  • Contact Us |
  • Jobs |
  • User Agreement |
  • Privacy Policy |
  • About our ads
LEGAL STUFF:
  • © 2005-2012 Newsvine, Inc. |
  • Newsvine® is a registered trademark of Newsvine, Inc. |
  • Newsvine is a property of msnbc.com